Literature DB >> 7248985

Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study.

J van Eys, T Chen, T Moore, W Cheek, C Sexauer, K Starling.   

Abstract

In a prospective, randomized, cooperative group trial, the value of iv vincristine and intrathecal methotrexate and hydrocortisone as adjuvant therapy to radiotherapy in children with medulloblastoma and ependymoma was evaluated. The data showed no improvement in the survival of such children when adjuvant therapy was given.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7248985

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


  6 in total

1.  Fourth ventricle ependymomas. A study of 20 cases with survival analysis.

Authors:  L Ferrante; L Mastronardi; G Schettini; P Lunardi; A Fortuna
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 2.  Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.

Authors:  B H Cohen; R J Packer
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

3.  Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.

Authors:  Irene Slavc; Elisabeth Schuller; Jutta Falger; Mehmet Günes; Konrad Pillwein; Thomas Czech; Wolfgang Dietrich; Karl Rössler; Karin Dieckmann; Daniela Prayer; Johannes Hainfellner
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

4.  Early response and long-term results in the radiotherapy of childhood medulloblastoma.

Authors:  H W Chin; Y Maruyama
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Medulloblastoma: histological evaluation and prognosis. A clinical, immunohistochemical and electron microscopic study.

Authors:  J Szymas; W Biczysko; P Gabryel; S Morkowski
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

6.  Childhood medulloblastoma in Britain 1971-77: analysis of treatment and survival.

Authors:  C A Stiller; E L Lennox
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.